StonvexLoading…
StonvexStonvexStonvexCore line items from CRCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $708.78M | $712.54M | $765.15M | $886.30M |
Operating Income | $96.03M | $76.11M | $69.98M | $79.95M |
Net Income | $76.70M | $62.83M | $53.64M | $60.67M |
EPS (Diluted) | $0.35 | $0.29 | $0.24 | $0.28 |
Total Assets | $580.81M | $693.03M | $750.12M | $949.63M |
Total Liabilities | $237.25M | $226.27M | $215.25M | $276.89M |
Cash & Equivalents | $256.22M | $232.14M | $142.19M | $224.94M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 211.34M | 213.30M | 217.92M | 219.66M |